Compare MACOM Technology (MTSI) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MACOM Technology vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? MACOM Technology trades at $330.06 (market cap $24.61B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: MACOM Technology and Royalty Pharma plc Class A Ordinary Shares are close in size by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while MACOM Technology pays none. Which is the better fit depends on your goals — on Pluang, investors hold MACOM Technology for 6 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| MTSI | RPRX | |
|---|---|---|
Market Cap | $24.61B | $25.27B |
Volume | 1,594,575 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $409.68 | $63.96 |
52-Week Low | $122.18 | $35.44 |
Typical Hold Time | 6 Days | 1 Days |
Enterprise Value | $24.32B | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MACOM Technology
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
